|
1
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar
|
|
2
|
Cogliano VJ, Baan R, Straif K, et al:
Preventable exposures associated with human cancers. J Natl Cancer
Inst. 103:1827–1839. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lu B, Kumar A, Castellsagué X and Giuliano
AR: Efficacy and safety of prophylactic vaccines against cervical
HPV infection and diseases among women: a systematic review and
meta-analysis. BMC Infect Dis. 11:132011. View Article : Google Scholar
|
|
4
|
Smith JS, Lindsay L, Hoots B, et al: Human
papillomavirus type distribution in invasive cervical cancer and
high-grade cervical lesions: a meta-analysis update. Int J Cancer.
121:621–632. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Malagón T, Drolet M, Boily MC, et al:
Cross-protective efficacy of two human papillomavirus vaccines: a
systematic review and meta-analysis. Lancet Infect Dis. 12:781–789.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Committee on Infectious D: HPV vaccine
recommendations. Pediatrics. 129:602–605. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tay SK: Cervical cancer in the human
papillomavirus vaccination era. Curr Opin Obstet Gynecol. 24:3–7.
2012. View Article : Google Scholar
|
|
8
|
Sankaranarayanan R: HPV vaccination: the
promise & problems. Indian J Med Res. 130:322–326.
2009.PubMed/NCBI
|
|
9
|
Kohli M, Ferko N, Martin A, et al:
Estimating the long-term impact of a prophylactic human
papillomavirus 16/18 vaccine on the burden of cervical cancer in
the UK. Br J Cancer. 96:143–150. 2007. View Article : Google Scholar
|
|
10
|
Brewer NT and Fazekas KI: Predictors of
HPV vaccine acceptability: a theory-informed, systematic review.
Prev Med. 45:107–114. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dahlström LA, Tran TN, Lundholm C, Young
C, Sundström K and Sparén P: Attitudes to HPV vaccination among
parents of children aged 12–15 years - a population-based survey in
Sweden. Int J Cancer. 126:500–507. 2010. View Article : Google Scholar
|
|
12
|
Allen JD, Coronado GD, Williams RS, et al:
A systematic review of measures used in studies of human
papillomavirus (HPV) vaccine acceptability. Vaccine. 28:4027–4037.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Arrossi S, Paolino M and Sankaranarayanan
R: Challenges faced by cervical cancer prevention programs in
developing countries: a situational analysis of program
organization in Argentina. Rev Panam Salud Publica. 28:249–257.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Programa nacional de prevención de cáncer
de cérvico-uterino. Datos Epidemiológicos. Minesterio de Salud;
Buenos Aires, Argentina. 2011.
|
|
15
|
De Maio FG, Linetzky B and Ferrante D:
Changes in the social gradients for Pap smears and mammograms in
Argentina: evidence from the 2005 and 2009 National Risk Factor
Surveys. Public Health. 126:821–826. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bruni L, Diaz M, Castellsagué X, Ferrer E,
Bosch FX and de Sanjosé S: Cervical human papillomavirus prevalence
in 5 continents: meta-analysis of 1 million women with normal
cytological findings. J Infect Dis. 202:1789–1799. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Badano I, Pedrozo RW, Ruiz Diaz LS, et al:
Human papillomavirus (HPV) detection and Papanicolaou cytology in
low-resource women in Posadas city, Misiones, Argentina. Rev Argent
Microbiol. 43:263–267. 2011.
|
|
18
|
Chouhy D, D’Andrea RM, Iglesias M, et al:
Prevalence of human papillomavirus infection in Argentinean women
attending two different hospitals prior to the implementation of
the National Vaccination Program. J Med Virol. 85:655–666. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Deluca GD, Marin HM, Blanco NS, et al:
Distribution of human papillomavirus genotypes in women with
cervical alterations from north Argentina. Indian J Med Microbiol.
31:138–141. 2013.PubMed/NCBI
|
|
20
|
HPV vaccine in Argentina: a leap forward
for girls’ and women’s health. World Health Organization (WHO);
Geneva, Switzerland: 2013
|
|
21
|
Ciapponi A, Bardach A, Glujovsky D,
Gibbons L and Picconi MA: Type-specific HPV prevalence in cervical
cancer and high-grade lesions in Latin America and the Caribbean:
systematic review and meta-analysis. PLoS One. 6:e254932011.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Colantonio L, Gómez JA, Demarteau N,
Standaert B, Pichón-Rivière A and Augustovski F: Cost-effectiveness
analysis of a cervical cancer vaccine in five Latin American
countries. Vaccine. 27:5519–5529. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Muñoz N, Franco EL, Herrero R, et al:
Recommendations for cervical cancer prevention in Latin America and
the Caribbean. Vaccine. 26(Suppl 11): L96–L107. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Arrossi S, Maceira V, Paolino M and
Sankaranarayanan R: Acceptability and uptake of HPV vaccine in
Argentina before its inclusion in the immunization program: a
population-based survey. Vaccine. 30:2467–2474. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bair RM, Mays RM, Sturm LA and Zimet GD:
Acceptability of the human papillomavirus vaccine among Latina
mothers. J Pediatr Adolesc Gynecol. 21:329–334. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dinh TA, Rosenthal SL, Doan ED, et al:
Attitudes of mothers in Da Nang, Vietnam toward a human
papillomavirus vaccine. J Adolesc Health. 40:559–563. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fazekas KI, Brewer NT and Smith JS: HPV
vaccine acceptability in a rural Southern area. J Womens Health.
17:539–548. 2008. View Article : Google Scholar
|
|
28
|
Lazcano-Ponce E, Rivera L,
Arillo-Santillán E, Salmerón J, Hernández-Avila M and Muñoz N:
Acceptability of a human papillomavirus (HPV) trial vaccine among
mothers of adolescents in Cuernavaca, Mexico. Arch Med Res.
32:243–247. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lee FH, Paz-Soldan VA, Carcamo C and
Garcia PJ: Knowledge and attitudes of adult peruvian women
vis-à-vis Human Papillomavirus (HPV), cervical cancer, and the HPV
vaccine. J Low Genit Tract Dis. 14:113–117. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sundström K, Tran TN, Lundholm C, Young C,
Sparén P and Dahlström LA: Acceptability of HPV vaccination among
young adults aged 18–30 years - a population based survey in
Sweden. Vaccine. 28:7492–7500. 2010. View Article : Google Scholar
|
|
31
|
Franco EL, Tsu V, Herrero R, et al:
Integration of human papillomavirus vaccination and cervical cancer
screening in Latin America and the Caribbean. Vaccine. 26(Suppl
11): L88–L95. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Winkler JL, Wittet S, Bartolini RM, et al:
Determinants of human papillomavirus vaccine acceptability in Latin
America and the Caribbean. Vaccine. 26(Suppl 11): L73–79. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Woodhall SC, Lehtinen M, Verho T, Huhtala
H, Hokkanen M and Kosunen E: Anticipated acceptance of HPV
vaccination at the baseline of implementation: a survey of parental
and adolescent knowledge and attitudes in Finland. J Adolesc
Health. 40:466–469. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Holman DM, Benard V, Roland KB, Watson M,
Liddon N and Stokley S: Barriers to human papillomavirus
vaccination among US adolescents: a systematic review of the
literature. JAMA Pediatr. 168:76–82. 2014. View Article : Google Scholar
|
|
35
|
Mayhew A, Mullins TL, Ding L, et al: Risk
perceptions and subsequent sexual behaviors after HPV vaccination
in adolescents. Pediatrics. 133:404–411. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ratanasiripong NT: Human papillomavirus
vaccine increases high-risk sexual behaviors: a myth or valid
concern. J Sch Nurs. 30:456–463. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Rysavy MB, Kresowik JD, Liu D, Mains L,
Lessard M and Ryan GL: Human papillomavirus vaccination and sexual
behavior in young women. J Pediatr Adolesc Gynecol. 27:67–71. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Bednarczyk RA, Davis R, Ault K, Orenstein
W and Omer SB: Sexual activity-related outcomes after human
papillomavirus vaccination of 11- to 12-year-olds. Pediatrics.
130:798–805. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Forster AS, Marlow LA, Stephenson J,
Wardle J and Waller J: Human papillomavirus vaccination and sexual
behaviour: cross-sectional and longitudinal surveys conducted in
England. Vaccine. 30:4939–4944. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Paolino M and Arrossi S: Women’s knowledge
about cervical cancer, Pap smear and human papillomavirus and its
relation to screening in Argentina. Women Health. 51:72–87. 2011.
View Article : Google Scholar : PubMed/NCBI
|
